Angiotensin II–Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer-Reference-Cited by-同舟云学术

Angiotensin II–Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer

Published:2016-08-01 Issue:8 Volume:2 Page:1030
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Boekhout Annelies H.¹,Gietema Jourik A.²,Milojkovic Kerklaan Bojana¹,van Werkhoven Erik D.³,Altena Renske²,Honkoop Aafke⁴,Los Maartje⁵,Smit Willem M.⁶,Nieboer Peter⁷,Smorenburg Carolien H.⁸,Mandigers Caroline M. P. W.⁹,van der Wouw Agnes J.¹⁰,Kessels Lonneke¹¹,van der Velden Annette W. G.¹²,Ottevanger Petronella B.¹³,Smilde Tineke¹⁴,de Boer Jaap¹⁵,van Veldhuisen Dirk J.¹⁶,Kema Ido P.¹⁷,de Vries Elisabeth G. E.²,Schellens Jan H. M.¹⁸

Affiliation:

1. Division of Clinical Pharmacology, Netherlands Cancer Institute, Amsterdam, the Netherlands

2. Department of Medical Oncology University Medical Center Groningen, University of Groningen, Groningen, the Netherlands

3. Biometrics Department, Netherlands Cancer Institute, Amsterdam, the Netherlands

4. Department of Internal Medicine, Isala Clinics, Zwolle, the Netherlands

5. Department of Internal Medicine, Antonius Hospital, Nieuwegein, the Netherlands

6. Department of Internal Medicine, Medisch Spectrum Twente, Enschede, the Netherlands

7. Department of Internal Medicine, Wilhelmina Hospital, Assen, the Netherlands

8. Department of Internal Medicine, Medical Center Alkmaar, Alkmaar, the Netherlands

9. Department of Internal Medicine, Canisius Wilhemina Hospital, Nijmegen, the Netherlands

10. Department of Internal Medicine, VieCuri Medical Center Noord-Limburg, Venlo, the Netherlands

11. Department of Internal Medicine, Deventer Hospital, Deventer, the Netherlands

12. Department of Internal Medicine, Martini Hospital, Groningen, the Netherlands

13. Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands

14. Department of Internal Medicine, Jeroen Bosch Hospital, Den Bosch, the Netherlands

15. Department of Internal Medicine, Hospital de Tjongerschans, Heerenveen, the Netherlands

16. Department of Cardiology, University Medical Center Groningen, the Netherlands

17. Department of Laboratory Medicine University Medical Center Groningen, University of Groningen, Groningen, the Netherlands

18. Division of Clinical Pharmacology, Netherlands Cancer Institute, Amsterdam, the Netherlands18Department of Pharmaceutical Sciences, Science Faculty Utrecht University, Utrecht, the Netherlands

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic factors in the pathogenesis of cardio-oncology;Journal of Translational Medicine;2024-08-05

2. Prevention of Anthracyclines and HER2 Inhibitor-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis;Cancers;2024-06-30

3. Prevention of anthracycline and trastuzumab‐induced decline in left ventricular ejection fraction with angiotensin‐converting enzyme inhibitors or angiotensin receptor blocker: a narrative systematic review of randomised controlled trials;Internal Medicine Journal;2024-06-14

4. Prophylaxis to Prevent Cardiotoxicity in Patients Receiving Anthracycline for Breast Cancer: A Combined Bayesian and Frequentist Network Meta-Analysis of Randomised Controlled Trials;Heart, Lung and Circulation;2024-05

5. Functional Validation of Doxorubicin-Induced Cardiotoxicity-Related Genes;JACC: CardioOncology;2024-02